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Abstract 
Background  Elderly patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) may present delirium but its 
clinical relevance is unknown. This study aimed at determining the clinical associated factors, and prognostic implications of delirium in 
old-aged patients admitted for NSTE-ACS. Methods  LONGEVO-SCA is a prospective multicenter registry including unselected patients 
with NSTE-ACS aged  80 years. Clinical variables and a complete geriatric evaluation were assessed during hospitalization. The associa-
tion between delirium and 6-month mortality was assessed by a Cox regression model weighted for a propensity score including the potential 
confounding variables. We also analysed its association with 6-month bleeding and cognitive or functional decline. Results  Among 527 
patients included, thirty-seven (7%) patients presented delirium during the hospitalization. Delirium was more frequent in patients with 
dementia or depression and in those from nursing homes (27.0% vs. 3.1%, 24.3% vs. 11.6%, and 11.1% vs. 2.2%, respectively; all P < 0.05). 
Delirium was significantly associated with in-hospital infections (27.0% vs. 5.3%, P < 0.001) and usage of diuretics (70.3% vs. 49.8%, P = 
0.02). Patients with delirium had longer hospitalizations [median 8.5 (5.514) vs. 6.0 (4.010) days, P = 0.02] and higher incidence of 
6-month bleeding and mortality (32.3% vs. 10.0% and 24.3% vs. 10.8%, respectively; both P < 0.05) but similar cognitive or functional 
decline. Delirium was independently associated with 6-month mortality (HR = 1.47, 95% CI: 1.022.13, P = 0.04) and 6-month bleeding 
events (OR = 2.87; 95% CI: 1.984.16, P < 0.01). Conclusions  In-hospital delirium in elderly patients with NSTE-ACS is associated with 
some preventable risk factors and it is an independent predictor of 6-month mortality. 
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1  Introduction 
Elderly patients represent roughly one-third of all admis-
sions for non-ST-segment elevation acute coronary syn-
drome (NSTE-ACS),[1,2] and an increase in this proportion is 
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foreseen in the coming years.[3] These patients frequently 
associate comorbidities such as dementia and frailty,[4] and 
they are known to have higher mortality,[1] and to receive 
less evidence-based treatments.[5] Therefore, identifying 
clinical predictors of worse outcomes in this specific popu-
lation is mandatory. 
Delirium is an acute disturbance of attention and cogni-
tive functioning that frequently complicates hospitalization 
of old-aged patients.[6] Although this condition and its sig-
nificance has been extensively studied in critical, medical, 
and even surgical care populations,[7–9] little is known about 
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its frequency in elderly patients admitted for NSTE-ACS 
and its impact on their clinical evolution. Given that risk- 
stratification tools for acute coronary syndrome (ACS) do 
not consider specific geriatric factors,[10,11] analysis of these 
conditions, such as delirium, may be of potential utility in 
clinical practice. 
This study aimed to describe the clinical associated fac-
tors and the prognostic implications of delirium in a large 
multicenter cohort of unselected elderly patients; aged  ≥ 
80 years, admitted for NSTE-ACS. 
2  Methods 
2.1  Study population 
The study population consists of 527 patients from the 
LONGEVO-SCA registry. The detailed study design and vari-
ables have been published previously.[12] Briefly, LON-
GEVO-SCA is a Spanish multicenter, prospective, observa-
tional study conducted between March 2016 and September 
2016. We enrolled consecutive elderly patients admitted for 
NSTE-ACS in 44 tertiary and secondary hospitals. The in-
clusion criteria were: (1) age ≥ 80 years; (2) chest pain con-
sistent with ACS; and (3) changes on ECG (negative T- 
wave or ST-segment decline) and/or elevation of myocardial 
damage biomarkers. The exclusion criteria were: (1) patient 
refusal to participate in the registry; and (2) impossibility of 
obtaining the geriatric tests. Patients with severe comorbid-
ities were only excluded if symptoms of myocardial ische-
mia were clearly triggered only by other conditions, such as 
acute anemia, severe decompensated respiratory insuffi-
ciency, active infectious diseases or severe coexisting val-
vular disease (type 2 myocardial infarction). The inclusion 
in the study did not imply any change in patients’ clinical 
management; therefore, the medical treatment, the comple-
mentary examinations including the need for coronary an-
giography or the choice of stents were decided by the 
medical team. Informed consent was obtained from the pa-
tients or their next of kin. The study was approved by the 
ethics committees of each center and the investigation con-
forms to the principles outlined in the Declaration of Hel-
sinki. The project was supported and coordinated by the 
Section of Geriatric Cardiology, Spanish Society of Cardi-
ology. 
2.2  Study variables 
Data were collected using specifically designed web 
forms (http://www.adknoma.com/LONGEVO-SCA), and 
quality controls were undertaken every month. We recorded 
the following clinical variables at study inclusion: (1) demo-
graphic and previous clinical history including comorbid-
ities; (2) case history and physical examination; (3) ECG, 
laboratory blood test and echocardiography at admission; (4) 
coronary angiography and coronary angioplasty when per-
formed; and (5) medical treatment and clinical evolution. 
Standard criteria were used to define each variable. Delir-
ium was defined as an acute and transient disorder of atten-
tion, and cognition and its diagnosis was made by the pa-
tient’s medical team following the current recommendations 
and methods.[13,14] Bleeding events were defined as signifi-
cant hemorrhages requiring surgery, hospitalization or anti-
thrombotic therapy withdrawal. A baseline geriatric assess-
ment was made during admission in all patients through 
interview with the patient, family or caregivers and referring 
to the patient’s status prior to admission. The complete 
in-hospital geriatric evaluation included the Barthel index 
(functional capacity), the Lawton-Brody Index (instrumen-
tal activities), the Pfeiffer test (cognitive status), the FRAIL 
scale (frailty), the Short Physical Performance Battery 
(SSPB) (frailty), the Charlson Comorbidity Index and the 
Nutritional Assessment–Short Form.[15–21]  
2.3  Follow-up 
Follow-up data was obtained by telephone contact at 
6-month, and from the event reports by electronic records of 
each hospital. The occurrence of death, major bleeding or 
the need of new coronary interventions was registered. Ad-
ditionally, a new geriatric evaluation was also determined 
by assessing the Barthel and Lawton indexes and the Pfeif-
fer test. Cognitive decline was defined as a loss of at least 
one point in the 6-month Pfeifer test. Functional decline was 
defined as a loss of at least ten points in the 6-month Barthel 
score or two points in the 6-month Lawton-Brody test.[22]  
2.4  Statistical analyses 
Categorical variables were described by frequencies and 
percentages, and statistical differences were analyzed using 
the χ2 test or Fisher exact test when any expected cell fre-
quency was < 5. The continuous variables were described 
either by the mean and standard deviation, or by the median 
and interquartile range. The statistical differences among the 
continuous variables were analyzed using student’s t test in 
case of a normal distribution, or the Wilcoxon rank-sum test 
in case of a non-normal distribution. Kaplan-Meier estima-
tors of survival were built comparing patients who suffered 
delirium and those who did not. Finally, to evaluate the in-
dependent effect of delirium on 6-month mortality, a Cox 
regression model was implemented adjusting for propensity 
score weights (inverse probability of assignment weighting) 
including the potential confounding variables.[23] For ana-
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lyzing the association between delirium and the secondary 
end-point (6-month bleeding events), we used a logistic 
regression adjusted by the previously described method. 
Multiple imputation using chained equations method was 
applied when necessary (n = 5) applying the “mice” pack-
age in the R Project for Statistical Computing.[24] A P value 
< 0.05 was considered significant. All analyses were per-
formed using STATA v.13 (StataCorp. 2013. Stata Statisti-
cal Software: Release 13. College Station, TX: StataCorp 
LP) and R software (R Foundation for Statistical Computing, 
version 3.3.2). 
3  Results 
3.1  Clinical characteristics 
From 527 patients, 37 (7%) presented delirium during 
hospitalization. Table 1 summarizes the baseline clinical 
characteristics of the study population. Patients who deve-
loped delirium had more frequently a previous diagnosis of 
dementia or depression. We did not find statistically signi-
ficant differences in any other main clinical characteristics 
between the two groups. Of note, there was a tendency 
towards a higher frequency of previous diagnosis of cere-
brovascular disease and heart failure in those who presented 
delirium. 
Table 2 shows the main features regarding the index 
hospitalization, the ACS characteristics and the procedures 
performed. Patients who presented delirium were more fre-
quently referred from nursing homes. At admission, they 
had a higher Killip class, higher CRUSADE score punc-
tuation; and presented more frequently elevated troponin 
levels. With respect to in-hospital complications, patients 
who developed delirium presented a higher incidence of 
atrial fibrillation, infections requiring antibiotic treatment; 
and they were more often treated with invasive mechanical 
ventilation, diuretic therapy, amiodarone, and benzodiaze-
pines. On the other hand, both groups had similar rate of 
invasive treatment and coronary revascularization therapy 
during the admission. 
3.2  Geriatric evaluation 
Table 3 summarizes the baseline and 6-month geriatric 
evaluation data. Patients who developed delirium were more 
comorbid, they had worse functional and instrumental ca-
pacities, and they also presented a poorer cognitive function 
and cognitive status. Remarkably, the prevalence of frailty 
(FRAIL score ≥ 3) in the entire cohort was 27%, and re-
sulted higher in patients with delirium (44% vs. 26%, P = 
0.04). 
3.3  Outcome 
As shown in Figure 1, patients who developed delirium 
had higher non-adjusted overall 6-month mortality (24.3% 
vs. 10.8%, P = 0.01). Table 4 describes in-hospital and 
Table 1.  Characteristics of the study population. 
 All patients (n = 527) Delirium (n = 37) No delirium (n = 490) P-value 
Age, yrs 84.1 (82.187.1) 84.7 (82.187.7) 84.0 (82.187.0) 0.58 
Female 205 (39.8%) 19 (51.4%) 186 (38.0%) 0.11 
CV risk factors 
Smoker 194 (36.8%) 16 (43.2%) 178 (36.3%) 0.40 
Hypertension 454 (86.2%) 33 (89.2%) 421 (85.9%) 0.58 
Dyslipidemia 337 (64.0%) 21 (56.8%) 316 (64.5%) 0.35 
Diabetes mellitus 210 (39.9%) 18 (48.7%) 192 (39.2%) 0.26 
Medical history 
Peripheral arterial disease  71 (13.5%) 5 (13.5%) 66 (13.5%) 1.00 
Cerebrovascular disease 80 (15.2%)  9 (24.3%)  71 (14.5%)  0.11 
Chronic kidney disease 168 (31.9%)  14 (37.8%)  154 (31.4%)  0.42 
Myocardial infarction 184 (34.9%) 12 (32.4%) 172 (35.1%) 0.74 
Previous PCI 152 (28.8%) 12 (32.4%) 140 (28.6%) 0.62 
Heart failure 92 (17.5%) 10 (27.0%) 82 (16.7%) 0.12 
Atrial fibrillation 102 (19.4%) 5 (13.5%) 97 (19.8%) 0.35 
Malignancy 89 (16.9%) 4 (10.8%) 85 (17.4%) 0.31 
Dementia 25 (4.7%) 10 (27.0%) 15 (3.1%) < 0.01 
Depression 66 (12.5%) 9 (24.3%) 57 (11.6%) 0.04 
Data are presented as n (%) or median (interquartile range). CV: cardiovascular; PCI: percutaneous coronary intervention. 
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Table 2.  Acute coronary syndrome characteristics, care and procedures. 
 All patients (n = 527) Delirium (n = 37) No delirium (n = 490) P-value 
Admission source 
Home 511 (97.2%) 32 (88.9%) 479 (97.8%) 
Institutionalized 15 (2.9%) 4 (11.1%) 11 (2.2%) 
0.02 
Admission unit 
CCU/ICU 154 (29.2%) 14 (37.8%) 140 (28.6%) 
Cardiology ward 315 (59.8%) 19 (51.3%) 296 (60.4%) 
Internal medicine/Geriatrics 58 (11.0%) 4 (10.8%) 54 (11.0%) 
0.42 
ACS and hospitalization characteristics 
Killip class > I 149 (28.7%) 15 (42.9%) 134 (27.7%) 0.06 
GRACE score 165 ± 28 172 ± 32 165 ± 28 0.16 
CRUSADE score 41 ± 13 47 ± 12 41 ± 13 0.02 
Positive troponin 446 (84.6%) 36 (97.3%) 410 (83.7%) 0.03 
3-vessel disease 107 (27.4%) 11 (40.7%) 96 (26.4%) 0.11 
LVEF 55 (4561) 55 (4060) 55 (4562) 0.42 
In-hospital AF episode 52 (9.9%) 8 (21.6%) 44 (9.0%) 0.02 
Infection 36 (6.8%) 10 (27.0%) 26 (5.3%) < 0.01 
Blood test parameters 
Hemoglobin, g/dL 12.8 (11.514.0) 12.5 (11.213.6) 12.8 (11.514.0) 0.32 
Creatinine peak, mg/dL 1.1 (0.91.4) 1.0 (0.91.4) 1.1 (0.91.4) 0.94 
Glucose peak, mg/dL 143 (113200) 168 (132218) 140 (112199) 0.05 
Procedures 
Coronary angiography 398 (75.5%) 27 (73.0%) 371 (75.7%) 0.71 
Coronary revascularization 290 (72.7%) 20 (74.1%) 270 (72.6%) 0.87 
Orotracheal intubation 9 (1.7%) 3 (8.1%) 6 (1.2%) 0.02 
IABP 6 (1.1%) 1 (2.7%) 5 (1.0%) 0.35 
In-hospital medical therapy 
Aspirin 503 (95.5%) 36 (97.3%) 467 (95.3%) 1.00 
ADP-receptor blocker 483 (91.7%) 34 (91.9%) 449 (91.6%) 1.00 
LMWH 420 (79.7%) 33 (89.2%) 387 (79.0%) 0.14 
Unfractionated heparin 80 (15.8%) 8 (21.6%) 72 (14.7%) 0.26 
ACEI/ARB 395 (75.0%) 25 (67.6%) 370 (75.5%) 0.28 
Beta-blocker 415 (78.8%) 31 (83.8%) 384 (78.4%) 0.44 
Statins 481 (91.3%) 34 (91.9%) 447 (91.2%) 0.89 
Diuretic 270 (51.2%) 26 (70.3%) 244 (49.8%) 0.02 
Amiodarone 28 (5.3%) 7 (18.9%) 21 (4.3%) < 0.01 
Neuroleptic 78 (14.8%) 32 (86.5%) 46 (9.4%) < 0.01 
Benzodiazepines 261 (49.5%) 23 (62.2%) 238 (48.6%) 0.11 
Data are presented as means ± SD or n (%) or median (interquartile range). ACEI: angiotensin-converting-enzyme inhibitor; ACS: acute coronary syndrome; 
ADP: adenosine diphosphate; AF: atrial fibrillation; ARB: angiotensin II receptor blocker; CCU: coronary care unit; IABP: intra-aortic balloon pump; ICU: 
intensive care unit; LMWH: low-molecular-weight heparin; LVEF: left ventricular ejection fraction. 
 
6-month outcomes. Patients with delirium had more fre-
quent in-hospital and 6-month bleeding events and longer 
hospitalization. Our data did not reveal significant differ-
ences in the proportion of patients presenting 6-month func-
tional decline or 6-month cognitive decline. After a Cox 
regression analysis with propensity score weighting includ-
ing the following well balanced confounding factors: pre-
vious heart failure, depression, institutionalization, positive 
troponin, 3-vessel coronary artery disease, revascularization 
during admission, CRUSADE score, Killip class, atrial fib-
rillation episodes, need for mechanical ventilation, infection 
during hospitalization, diuretic treatment requirement, treat-
ment with amiodarone, treatment with benzodiazepines and 
frailty; delirium persisted as an independent risk factor  
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Table 3.  In-hospital and 6-month geriatric evaluation. 
 All patients (n = 527) Delirium (n = 37) No delirium (n = 490) P-value 
In-hospital geriatric evaluation 
Charlson (comorbidity) 2 (13) 3 (24) 2 (13) 0.01 
Barthel (daily activities) 100 (85100) 90 (58100) 100 (90100) < 0.01 
Lawton-Brody (instrumental) 6 (48) 4 (26) 6 (48) < 0.01 
Pfeifer (cognitive function) 1 (03) 4 (27) 1 (03) < 0.01 
MNA-FS (nutritional) 11 (1013) 10 (911) 11 (1013) < 0.01 
SPPB test (Frailty) 6 (29) 2 (15) 6 (39) < 0.01 
Frailty (FRAIL) 
No frailty (FRAIL = 0) 178 (34.2%) 8 (22.2%) 170 (35.1%) 
Pre-frailty (FRAIL 12) 202 (38.9%) 12 (33.3%) 190 (39.3%) 
Frailty (FRAIL ≥ 3) 140 (26.9%) 16 (44.4%) 124 (25.6%) 
0.04 
Frailty (SPPB < 10) 372 (81.8%) 28 (96.6%) 344 (80.8%) 0.03 
6-month geriatric evaluation 
Barthel 95 (80100) 90 (5095) 95 (80100) < 0.01 
Lawton-Brody 5 (37) 2.5 (04) 5 (37) < 0.01 
Pfeifer (cognitive function) 1 (03) 5 (29) 1 (02) < 0.01 
Data are presented as n (%) or median (interquartile range). MNA-FS: Mini Nutritional Assessment-Short Form; SPPB: short physical performance battery. 
 
 
Figure 1.  Kaplan-Meier estimators of survival comparing 
patients who presented delirium or not. Kaplan-Meier survival 
curves of mortality data comparing those patients who developed 
delirium or not during the admission with a follow-up duration of 6 
months (total n = 527), P-value is a log-rank test. 
associated with 6-month mortality (HR = 1.47; 95% CI: 
1.022.13, P = 0.04). Finally, a logistic regression analysis 
adjusted by the previously mentioned method showed that 
delirium was also independently associated with 6-month- 
bleeding events (OR = 2.87; 95% CI: 1.984.16, P < 0.01). 
4  Discussion 
4.1  Main findings 
Our large multicenter prospective cohort provides reli-
able data about the frequency, clinical characteristics and 
prognostic implications of delirium in patients aged 80 or 
older admitted for NSTE-ACS. Our results show that up to 
7% of octogenarians with NSTE-ACS develop delirium and 
that its appearance is a robust independent predictor of 
6-month mortality. Additionally, delirium identified patients 
with higher risk of bleeding events and longer hospitali-
zation. 
Table 4.  In-hospital and 6-month outcome. 
Univariate analysis All patients (n = 527) Delirium (n = 37) No delirium (n = 490) P-value 
In-hospital mortality 12 (2.3%) 2 (5.4%) 10 (2.0%) 0.20 
6-month mortality 62 (11.8%) 9 (24.3%) 53 (10.8%) 0.01 
In-hospital bleeding 41 (7.8%) 8 (21.6%) 33 (6.7%) < 0.01 
6-month bleeding 56 (11.5%) 10 (32.3%) 46 (10.0%) < 0.01 
Length of stay, d 6 (410) 8.5 (5.514) 6 (410) 0.02 
Cognitive decline* 122 (29.2%) 8 (36.4%) 114 (28.8%) 0.45 
Functional decline# 148 (33.3%) 13 (48.2%) 135 (32.4%) 0.09 
Data are presented as n (%) or median (interquartile range). *Gain of at least 1 point in the 6-month Pfeifer test; #Loss of at least 5 points in the 6-month Barthel score. 
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4.2  Delirium incidence 
The incidence of delirium in hospitalized patients de- 
pends on the setting of the study population. The highest 
rates have been described in postoperative populations 
(46%),[25] and in intensive-care unit ventilated patients 
(82%).[7] More specifically, an incidence of 20% has been 
reported in patients admitted to cardiac intensive care 
units,[26,27] and 17% in elderly patients admitted due to acute 
cardiac conditions.[28] In our study, the lower observed rate 
could be explained by the fact that the majority of our pa-
tients were admitted to the regular ward and they were 
overall in better clinical condition. For example, only 25% 
presented heart failure. Moreover, our study is based in a 
very recent cohort and it could be influenced by the growing 
interest and interventions designed for the prevention of 
specific geriatric complications.[29]   
4.3  Predisposing and precipitant factors for delirium 
The appearance of delirium depends on the coexistence 
of several predisposing characteristics and the presence of 
distinct insults that play the role of precipitating factors.[30] 
We identified depression, dementia or institutionalization as 
baseline characteristics that may help to recognize those 
patients more prone to present delirium. In addition, the 
geriatric tests show that the comorbidity, frailty and the 
diminution of the functional or cognitive capacities are var-
iables closely related to its appearance. All these findings 
are consistent with the previously published evidence,[31–34] 
and it could potentially be used to screen and identify those 
elderly patients admitted with NSTE-ACS, these patients 
need more a proactive implementation of preventive strate-
gies for delirium. Regarding the latter, our study shows 
some potentially preventable precipitants, such as infections 
or the use of diuretics. For instance, early removal of uri-
nary or venous catheters, and minimizing the duration of 
mechanical ventilation could be useful to prevent delir-
ium.[30] Additionally, excessive depletion of these patients 
leading to uremia or dyselectrolytemia are known to be re-
lated with delirium, and it should be reconsidered daily.[9] 
Finally, non-pharmacological multicomponent approaches 
for prevention of delirium are effective strategies likely ap-
plicable to this specific population.[35,36]  
4.4  Delirium and outcomes 
Delirium has been related to higher mortality in different 
medical and surgical populations,[37,38] and it has also been 
evaluated in patients with acute cardiac conditions. Uthama-
lingam, et al.[39] observed that delirium was independently 
associated with higher in-hospital and 90-day mortality in 
patients admitted with acute heart failure in a single center 
retrospective cohort study. In accordance with the above, 
Noriega, et al.[28] found that delirium was associated with 
higher adjusted 12-month mortality in old patients admitted 
for acute cardiac conditions; however, only a third of them 
were admitted due to ACS and all patients were included in 
the cardiology department of a single university hospital. 
Finally, in critical cardiac care settings, Pauley, et al.[26] and 
Sato, et al.[27] reported that delirium was independently as-
sociated with in-hospital and 60-day mortality, respectively. 
To our knowledge, this is the first study addressing the short 
and long-term prognostic implications of delirium in elderly 
patients admitted for NSTE-ACS in a large multicenter and 
non-selected population. We found that delirium is a robust 
independent predictor of 6-month mortality and thus, this 
information could be useful for risk stratification in this 
growing and complex population. Moreover, delirium also 
seems to be associated with a higher risk of bleeding and 
longer hospitalization. 
Validated risk scores are useful tools to predict outcomes 
in ACS,[10,11] and their use has been generalized in the last 
decade.[40] However, elderly NSTE-ACS patients have spe-
cific geriatric syndromes; such as frailty or delirium that 
may influence the prognosis,[41] and they are not considered 
in risk-stratification tools. In a recent cohort study in old 
patients admitted for ACS, frailty and comorbidity were 
identified as mortality predictors, and they were found to 
significantly reclassify risk beyond age.[42] Nonetheless, the 
specific impact of delirium was not studied and its potential 
predictive utility has not been tested. Based on our data, the 
appearance of delirium is related to a poorer prognosis and 
it should be useful when estimating the risk of death in these 
patients. Besides, since it is a potentially preventable and 
treatable cause, further research in this field would be of 
special interest. 
Finally, our findings show a high proportion of patients 
presenting 6-month cognitive and functional decline, but it 
did not result to be significantly associated with delirium. 
Delirium has a transient nature,[13] and these patients have a 
correct recovery after the index hospitalization. Therefore, 
the cognitive or functional decline observed may be associ-
ated to other important factors, such as age or previous cog-
nitive impairment.[43] 
4.5  Study limitations 
Our study has some limitations. This is a post-hoc analy-
sis, and it could be influenced by the usual biases of these 
types of studies. Additionally, given the descriptive nature 
of the study, there might be residual confusion affecting the 
association between delirium and mortality despite the ad-
justment by the propensity score. Moreover, some signifi-
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cant clinical variables as the presence of other geriatric syn-
dromes, such as immobility or urinary incontinence, and 
data about the use of physical restraints or central vein or 
urinary catheters are lacking. Finally, delirium was not 
screened daily; thus, it possibly lead to underdetection of 
hypoactive delirium. 
In conclusion, our study provides the first description re-
garding the unfavorable effect of delirium on the prognosis 
of elderly patients with NSTE-ACS. Our data, based on a 
broad and systematic geriatric assessment both on admis-
sion and 6 months after discharge, are of clinical interest 
and it may potentially pave the way to the addition of spe-
cific geriatric syndromes to currently existing risk scores in 
this population. 
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